Makoto Onizuka, Eri Kikkawa, Shinichiro Machida, Masako Toyosaki, Rikio Suzuki, Daisuke Ogiya, Yasuyuki Aoyama, Jun Amaki, Kaito Harada, Ryujiro Hara, et al. Association of CDKN2A/2B deletion with relapse after hematopoietic stem cell transplantation for acute lymphoblastic leukemia. Blood cell therapy. 2023. 6. 3. 80-86
Daisuke Minakata, Tadao Ishida, Kiyoshi Ando, Rikio Suzuki, Junji Tanaka, Shotaro Hagiwara, Revathi Ananthakrishnan, Shigeki Kuwayama, Mitsufumi Nishio, Yoshinobu Kanda, et al. Phase 2 results of idecabtagene vicleucel (ide-cel, bb2121) in Japanese patients with relapsed and refractory multiple myeloma. International journal of hematology. 2023. 117. 5. 729-737
Rikio Suzuki, Daisuke Ogiya, Yoshiaki Ogawa, Hiroshi Kawada, Kiyoshi Ando. Targeting CAM-DR and Mitochondrial Transfer for the Treatment of Multiple Myeloma. Current oncology (Toronto, Ont.). 2022. 29. 11. 8529-8539